当前位置: X-MOL 学术Ther. Adv. Med. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
Therapeutic Advances in Medical Oncology ( IF 4.3 ) Pub Date : 2019-06-06 , DOI: 10.1177/1758835919855491
Federica Riccardo 1 , Lidia Tarone 2 , Selina Iussich 3 , Davide Giacobino 3 , Maddalena Arigoni 4 , Federica Sammartano 3 , Emanuela Morello 3 , Marina Martano 3 , Francesca Gattino 3 , Raffaella De Maria 3 , Soldano Ferrone 5 , Paolo Buracco 3 , Federica Cavallo 2
Affiliation  

Osteosarcoma (OSA) is the most common primary malignant tumor of the bones. Of note, OSA is the sixth most-frequent pediatric cancer and represents the second most common cause of cancer-related death in this age group; a second peak is observed in adults after the sixth decade of life.1,2 Currently, primary OSA is classified into low- (Grade I) and high-grade subtypes (Grade II and III in the presence of metastasis), high-grade OSA being the most prevalent and aggressive variant.3

中文翻译:

将 CSPG4 鉴定为骨肉瘤转化组合方法的有希望的靶点

骨肉瘤(OSA)是最常见的原发性骨骼恶性肿瘤。值得注意的是,OSA 是第六大最常见的儿科癌症,是该年龄段癌症相关死亡的第二大常见原因;在 60 岁后的成年人中观察到第二个高峰。1,2目前,原发性 OSA 分为低级别(I 级)和高级别亚型(存在转移的 II 级和 III 级),高级别 OSA 是最普遍和最具侵袭性的变体。3
更新日期:2019-06-06
down
wechat
bug